ciglitazone and cyclin d1

ciglitazone has been researched along with cyclin d1 in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (76.92)29.6817
2010's3 (23.08)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hupfeld, CJ; Weiss, RH1
Burghardt, R; Qin, C; Safe, S; Smith, R; Stewart, J; Wormke, M1
Ethridge, RT; Evers, BM; Hashimoto, K1
Fakhry, I; Gehr, TW; Ghosh, S; Ghosh, SS; Lyall, V; Schoolwerth, AC; Sica, DA1
Fisher, PB; Han, S; Roman, J; Sidell, N1
Xu, YJ; Zhang, HL; Zhang, ZX1
Brueggemeier, RW; Chen, CS; Chen, KF; Huang, JW; Kulp, SK; Shapiro, CL; Shiau, CW; Yang, YT1
Xing, L; Zhang, H; Zhang, W1
Aiello, A; Belfiore, A; Conte, E; Frasca, F; Genua, M; Murabito, A; Pandini, G; Sacco, A; Vigneri, R1
Akinyeke, TO; Lyles, BE; Moss, PE; Stewart, LV1
Black, JL; Burgess, JK; Lau, JY; Moir, LM; Oliver, BG1
Chu, X; Liu, M; Pei, L; Wang, R; Yu, W; Zhang, J; Zhang, Y; Zhu, X1
Lyles, BE; Moss, PE; Stewart, LV1

Other Studies

13 other study(ies) available for ciglitazone and cyclin d1

ArticleYear
TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
    American journal of physiology. Endocrinology and metabolism, 2001, Volume: 281, Issue:2

    Topics: Animals; Becaplermin; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Division; Cells, Cultured; Culture Media, Serum-Free; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; DNA; Enzyme Inhibitors; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Platelet-Derived Growth Factor; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-sis; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Suppressor Proteins

2001
Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.
    Cancer research, 2003, Mar-01, Volume: 63, Issue:5

    Topics: Breast Neoplasms; Cell Division; Cyclin D1; Cysteine Endopeptidases; Down-Regulation; Estrogen Receptor alpha; G1 Phase; Humans; Multienzyme Complexes; Prostaglandin D2; Proteasome Endopeptidase Complex; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; RNA, Messenger; S Phase; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured; Ubiquitin

2003
Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    International journal of gastrointestinal cancer, 2002, Volume: 32, Issue:1

    Topics: 3T3 Cells; Adenocarcinoma; alpha Catenin; Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Cadherins; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Cycle; Cell Cycle Proteins; Cell Division; Collagen; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Cyclooxygenase 2; Cytoskeletal Proteins; Drug Combinations; Enzyme Induction; Gene Expression Regulation, Neoplastic; Humans; Isoenzymes; Laminin; Ligands; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Pancreatic Neoplasms; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Proteoglycans; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins

2002
PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase.
    Kidney international, 2003, Volume: 64, Issue:1

    Topics: Animals; Cell Cycle Proteins; Cell Division; Cells, Cultured; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Drug Synergism; Enzyme Inhibitors; Flavonoids; Gene Expression; Gene Expression Regulation; Genes, fos; Glomerular Mesangium; Ligands; Mice; Mitogen-Activated Protein Kinases; Phosphorylation; Platelet-Derived Growth Factor; Receptors, Cytoplasmic and Nuclear; Serum Response Element; Thiazolidinediones; Transcription Factors; Tumor Suppressor Proteins

2003
Ligands of peroxisome proliferator-activated receptor gamma inhibit lung cancer cell growth and induce apoptosis by stimulation of P21 expression.
    Chest, 2004, Volume: 125, Issue:5 Suppl

    Topics: Antineoplastic Agents; Apoptosis; Chromans; Cyclin D1; Humans; Lung Neoplasms; Prostaglandin D2; Proto-Oncogene Proteins p21(ras); Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Thiazolidinediones; Transcription Factors; Troglitazone

2004
[Ciglitazone inhibits growth of lung cancer cells A549 in vitro and in vivo: an experimental study].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2004, Volume: 26, Issue:9

    Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; PPAR gamma; Random Allocation; Resting Phase, Cell Cycle; Thiazolidinediones; Time Factors

2004
Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells.
    Molecular pharmacology, 2005, Volume: 67, Issue:4

    Topics: Breast Neoplasms; Cell Line, Tumor; Chromans; Cyclin D1; Down-Regulation; Female; Humans; PPAR gamma; Proteasome Endopeptidase Complex; Thiazolidinediones; Troglitazone

2005
Influence of ciglitazone on A549 cells growth in vitro and in vivo and mechanism.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2006, Volume: 26, Issue:1

    Topics: Animals; Cell Proliferation; Cyclin D1; Humans; Lung Neoplasms; Mice; Mice, Nude; PPAR gamma; Random Allocation; Thiazolidinediones; Tumor Cells, Cultured

2006
Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Endocrinology, 2006, Volume: 147, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Carcinoma; Caspase 3; Caspase 7; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Epithelial Cells; Gene Expression; Humans; Insulin-Like Growth Factor I; Intracellular Signaling Peptides and Proteins; Luciferases; Mesoderm; Phosphorylation; PPAR gamma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Retinoblastoma Protein; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Thyroid Neoplasms; Transfection

2006
Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.
    Cell cycle (Georgetown, Tex.), 2009, Jan-15, Volume: 8, Issue:2

    Topics: Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Humans; Male; PPAR gamma; Prostatic Neoplasms; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones

2009
Differential expression of peroxisome proliferator activated receptor gamma and cyclin D1 does not affect proliferation of asthma- and non-asthma-derived airway smooth muscle cells.
    Respirology (Carlton, Vic.), 2010, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androstadienes; Asthma; Bronchi; Bronchodilator Agents; Cell Proliferation; Cells, Cultured; Cyclin D1; Female; Fluticasone; Humans; Male; Middle Aged; Mitogens; Myocytes, Smooth Muscle; PPAR gamma; RNA, Messenger; Thiazolidinediones; Young Adult

2010
Peroxisome proliferator-activated receptor gamma promotes neuroprotection by modulating cyclin D1 expression after focal cerebral ischemia.
    Canadian journal of physiology and pharmacology, 2010, Volume: 88, Issue:7

    Topics: Animals; Brain Ischemia; Cell Survival; Cells, Cultured; Cerebral Cortex; Cyclin D1; Male; Neurons; Neuroprotective Agents; PPAR gamma; Rats; Rats, Sprague-Dawley; Thiazolidinediones

2010
The PPARĪ³ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
    Experimental cell research, 2010, Dec-10, Volume: 316, Issue:20

    Topics: Androgen-Binding Protein; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dihydrotestosterone; Gene Expression; Genes, Reporter; Humans; Hypoglycemic Agents; Male; Mutation; Neoplasms, Hormone-Dependent; PPAR gamma; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Transfection

2010